Our projects

What we do

MZ-TECH provides training, and technical support and participates in meetings of healthcare facilities committees to reduce the risk of mortality from advanced HIV disease.

The World Health Organization (WHO) estimates that one in three people living with HIV (PLHIV) who are in care have advanced disease and are at high risk of death from serious illness (advanced disease).

The mortality rate for patients with advanced disease ranges from 25% to 50%. In one-third of these cases, mortality occurs within the first 48 hours of hospitalization.Another 20% die in the outpatient setting after discharge and about 30% are readmitted to the hospital soon after discharge because their condition has worsened or new serious conditions have developed.

In order to reduce the risk of mortality in this group of patients (due to advanced disease), the implementation of a comprehensive clinical care package is recommended.

1. Guide to the management of patients with advanced HIV disease. Ministry of Health (MISAU), National Directorate of Public Health - National STI/HIV and AIDS Control Programme.

2. Ibid

Advanced HIV disease project (AHD)

MZ-TECH supports health facilities (HF) in Mozambique in the implementation of the Advanced HIV Disease (AHD) policy by providing training, capacity building and technical assistance to HF providers on the appropriate management of patients with advanced HIV disease.

Clinical care package

Project interventions

Screening

Screening for the diagnosis of major opportunistic infections using a variety of available testing platforms, including rapid tests.

Treatment

Prophylactic treatment for the most serious and/or common opportunistic infections that can lead to death.

Optimization

Provision of optimized antiretroviral (ARV) regimens. ARVs should be started or switched to other regimens as soon as possible.